153 related articles for article (PubMed ID: 6927729)
1. Glycosylated hemoglobin and fasting plasma glucose in the assessment of outpatient glycemic control in NIDDM.
Pecoraro RE; Chen MS; Porte D
Diabetes Care; 1982; 5(6):592-9. PubMed ID: 6927729
[TBL] [Abstract][Full Text] [Related]
2. Comparative clinical reliability of fasting plasma glucose and glycosylated hemoglobin in non-insulin-dependent diabetes mellitus.
Pecoraro RE; Koepsell TD; Chen MS; Lipsky BA; Belcher DW; Inui TS
Diabetes Care; 1986; 9(4):370-5. PubMed ID: 3743312
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group.
Simonson DC; Kourides IA; Feinglos M; Shamoon H; Fischette CT
Diabetes Care; 1997 Apr; 20(4):597-606. PubMed ID: 9096986
[TBL] [Abstract][Full Text] [Related]
4. Glycosylated hemoglobin concentration for assessment of glycemic control in diabetic cats.
Elliott DA; Nelson RW; Feldman EC; Neal LA
J Vet Intern Med; 1997; 11(3):161-5. PubMed ID: 9183767
[TBL] [Abstract][Full Text] [Related]
5. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
Chow CC; Tsang LW; Sorensen JP; Cockram CS
Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
[TBL] [Abstract][Full Text] [Related]
6. Comparison of glycated hemoglobin with fasting plasma glucose in definition of glycemic component of the metabolic syndrome in an Iranian population.
Janghorbani M; Amini M
Diabetes Metab Syndr; 2012; 6(3):136-9. PubMed ID: 23158976
[TBL] [Abstract][Full Text] [Related]
7. A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patients.
Davidson J; Koro C; Arondekar B; Lee BH; Fedder D
Clin Ther; 2008 Feb; 30(2):287-93. PubMed ID: 18343267
[TBL] [Abstract][Full Text] [Related]
8. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels.
Woerle HJ; Neumann C; Zschau S; Tenner S; Irsigler A; Schirra J; Gerich JE; Göke B
Diabetes Res Clin Pract; 2007 Aug; 77(2):280-5. PubMed ID: 17240473
[TBL] [Abstract][Full Text] [Related]
9. Glycosylated hemoglobin in endogenous hypertriglyceridemia.
Fedele D; Lapolla A; Cardone C; Baldo G; Crepaldi G
Acta Diabetol Lat; 1983; 20(4):303-9. PubMed ID: 6666502
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the long-term durability and glycemic control of fasting plasma glucose and glycosylated hemoglobin for pioglitazone in Japanese patients with type 2 diabetes.
Stringer F; DeJongh J; Enya K; Koumura E; Danhof M; Kaku K
Diabetes Technol Ther; 2015 Mar; 17(3):215-23. PubMed ID: 25531677
[TBL] [Abstract][Full Text] [Related]
11. How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?
Bouma M; Dekker JH; de Sonnaville JJ; van der Does FE; de Vries H; Kriegsman DM; Kostense PJ; Heine RJ; van Eijk JT
Diabetes Care; 1999 Jun; 22(6):904-7. PubMed ID: 10372239
[TBL] [Abstract][Full Text] [Related]
12. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
Turner RC; Cull CA; Frighi V; Holman RR
JAMA; 1999 Jun; 281(21):2005-12. PubMed ID: 10359389
[TBL] [Abstract][Full Text] [Related]
13. Assessment of glycaemic control in non-insulin-dependent diabetes mellitus.
Wettre S; Arnqvist HJ; Von Schenck H
Scand J Clin Lab Invest; 1993 Apr; 53(2):163-70. PubMed ID: 8469915
[TBL] [Abstract][Full Text] [Related]
14. The effect of stress on glycemic control in patients with type II diabetes during glyburide and glipizide therapy.
Jaber LA; Lewis NJ; Slaughter RL; Neale AV
J Clin Pharmacol; 1993 Mar; 33(3):239-45. PubMed ID: 8463437
[TBL] [Abstract][Full Text] [Related]
15. Glycosylated serum protein levels assayed with highly sensitive immunoradiometric assay accurately reflect glycemic control of diabetic patients.
Gordon A; Glaser B; Wald M; Del Rio G; Della Casa L; Gross J; Cerasi E
Diabetes Care; 1992 May; 15(5):645-50. PubMed ID: 1516484
[TBL] [Abstract][Full Text] [Related]
16. Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus.
Gradman TJ; Laws A; Thompson LW; Reaven GM
J Am Geriatr Soc; 1993 Dec; 41(12):1305-12. PubMed ID: 8227912
[TBL] [Abstract][Full Text] [Related]
17. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
[TBL] [Abstract][Full Text] [Related]
18. Comparison of serum fructosamine and blood glycosylated hemoglobin concentrations for assessment of glycemic control in cats with diabetes mellitus.
Elliott DA; Nelson RW; Reusch CE; Feldman EC; Neal LA
J Am Vet Med Assoc; 1999 Jun; 214(12):1794-8. PubMed ID: 10382020
[TBL] [Abstract][Full Text] [Related]
19. Is red cell sorbitol content a good marker of glycemic control in diabetic patients?
Lapolla A; Poli T; Valerio A; Fedele D
Diabetes Res; 1985 Nov; 2(6):283-6. PubMed ID: 4075698
[TBL] [Abstract][Full Text] [Related]
20. Glycemic control predicts diabetic extrarenal microvascular complications but not renal survival in patients with moderate to severe chronic kidney disease.
Crook ED; Patel S
Ethn Dis; 2006; 16(4):865-71. PubMed ID: 17061739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
